Sirona Biochem Stock Forecast, Price & News

Sirona Biochem (CVE:SBM) Frequently Asked Questions

What stocks does MarketBeat like better than Sirona Biochem?

Wall Street analysts have given Sirona Biochem a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sirona Biochem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Sirona Biochem's stock price been impacted by COVID-19?

Sirona Biochem's stock was trading at C$0.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SBM shares have decreased by 21.7% and is now trading at C$0.24.
View which stocks have been most impacted by COVID-19.

Who are Sirona Biochem's key executives?

Sirona Biochem's management team includes the following people:

• Dr. Howard J. Verrico Ph.D., M.D., Founder, Chairman, CEO & Sec. (Age 60, Pay $161.28k)
• Mr. Christopher D. Hopton, CFO & Director (Age 55, Pay $147.84k)
• Dr. Géraldine Deliencourt-Godefroy, Chief Scientific Officer & Director
• Ms. Michelle Seltenrich MBA, VP of Operations
• Dr. Brett A. Premack Ph.D., Scientific Consultant

Who are some of Sirona Biochem's key competitors?

Some companies that are related to Sirona Biochem include Burcon NutraScience (BU), Bioventix (BVXP), Circassia Group (CIR), Arix Bioscience (ARIX), Novacyt (NCYT), e-therapeutics (ETX), Scancell (SCLP), Faron Pharmaceuticals Oy (FARN), Medicenna Therapeutics (MDNA), IMV (IMV), ImmunoPrecise Antibodies (IPA), BriaCell Therapeutics (BCT), Oncolytics Biotech (ONC), Open Orphan (ORPH) and Resverlogix (RVX).
View all of SBM's competitors.

What other stocks do shareholders of Sirona Biochem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP).

What is Sirona Biochem's stock symbol?

Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM."

How do I buy shares of Sirona Biochem?

Shares of SBM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Sirona Biochem's stock price today?

One share of SBM stock can currently be purchased for approximately C$0.24.

How much money does Sirona Biochem make?

Sirona Biochem has a market capitalization of C$54.13 million and generates C$343,833.00 in revenue each year.

What is Sirona Biochem's official website?

The official website for Sirona Biochem is www.sironabiochem.com.

How can I contact Sirona Biochem?

The company can be reached via phone at 604-641-4466.